Gene: EFCAB2
Official Full Name: dynein regulatory complex subunit 8provided by HGNC
Gene Summary: The gene encodes a protein that contains two EF-hand calcium-binding domains although its function has yet to be determined. Alternatively spliced transcripts have been observed. [provided by RefSeq, Mar 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24967 | EFCAB2 Knockout cell line (HeLa) | Human | EFCAB2 | 1:3~1:6 | Negative | Online Inquiry |
KO24968 | EFCAB2 Knockout cell line (HCT 116) | Human | EFCAB2 | 1:2~1:4 | Negative | Online Inquiry |
KO24969 | EFCAB2 Knockout cell line (HEK293) | Human | EFCAB2 | 1:3~1:6 | Negative | Online Inquiry |
KO24970 | EFCAB2 Knockout cell line (A549) | Human | EFCAB2 | 1:3~1:4 | Negative | Online Inquiry |
EFCAB2 Gene Knockout Cell Lines are genetically modified cellular models designed to study the function of the EFCAB2 gene, a crucial player in various cellular processes, including calcium signaling and interactions with other proteins. By employing CRISPR-Cas9 genome editing technology, these cell lines provide a precise and efficient means to investigate gene function and the consequences of gene knockout on physiological and pathological conditions. The knockout mechanism involves targeted disruption of the EFCAB2 gene, which allows researchers to analyze gene-specific effects on cellular behavior, including proliferation, differentiation, and apoptotic pathways.
The scientific importance of EFCAB2 Gene Knockout Cell Lines lies in their ability to facilitate research in multiple areas, including cancer biology, neurobiology, and immunology. They serve as valuable tools for elucidating the gene's role in health and disease, allowing for the exploration of therapeutic targets and the development of novel interventions. Additionally, these cell lines can be utilized in drug screening assays, helping to identify compounds that may selectively modulate the pathways associated with EFCAB2 function.
Compared to other genetic manipulation techniques, these knockout cell lines offer several distinct advantages. They provide a stable genetic background, which ensures consistent and reproducible experimental results. Moreover, the specificity of CRISPR-Cas9 gene editing minimizes off-target effects, thereby improving the reliability of findings. Researchers will find the EFCAB2 knockout cell lines particularly beneficial for high-throughput screening, functional assays, and in-depth mechanistic studies.
The value of EFCAB2 Gene Knockout Cell Lines to researchers and clinicians is underscored by their potential to accelerate the understanding of complex biological processes and to inform the development of targeted therapies. By leveraging these powerful tools, scientists can gain deeper insights into gene functionality and its implications in disease states.
Our company, recognized for its commitment to advancing genetic research and providing high-quality biological products, stands at the forefront of genetic engineering innovation. We offer a comprehensive range of genetically modified cell lines that support cutting-edge research, ensuring that our customers have the necessary tools to make meaningful scientific discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.